Computer Based Systems
(OMCL) Omnicell Analyst Reaffirms Shares at Neutral
We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $17.00.
Omnicell reported adjusted EPS of 9 cents in the third quarter of fiscal 2011, beating the Zacks...
(OMCL) Omnicell’s G4 Platform Reaches China
Recently, Omnicell (OMCL) announced the launch of Mandarin-language versions of its G4 platform for clinical use in China. Following the launch of G4 medication automation platform in English-speaking markets...
(OMCL) Omnicell Beats Estimates
Omnicell Inc. (OMCL) reported EPS of 9 cents during the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate of 8 cents and the year-ago quarter EPS of 4 cents. Reported earnings shot...
(OMCL) Omnicell Analyst Maintains Neutral on Shares
We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $16.00.
Omnicell reported an adjusted EPS of 8 cents in the second quarter of fiscal 2011, beating both the...
(OMCL) Omnicell’s Electronic Health Record Wins Certification
Omnicell, Inc. (OMCL), a leading developer and marketer of end-to-end automation solutions for the medication-use process, recently announced that its newly launched G4 platform received the ONC-ATCB certification...
(OMCL) Omnicell Earns Second Consecutive Best in Klas Award
Omnicell (OMCL), recently announced that it has received recognition for its OmniRx automated dispensing system from leading research firm, KLAS for the second consecutive year. Along with the 2011 “Best...
(EU) International Business Machine Faces Anti-trust Probes
The European Union (EU) has accused International Business Machine Corp. (IBM) of violating anti-trust guidelines and misusing its dominant position in the Mainframe computer market. The European Commission,...
(OMCL) Omnicell Incorporated – Bull of the Day
Hospital services like those provided by Omnicell, Inc. (OMCL) should exhibit strong growth over the long-term, benefiting from favorable demographic trends, regulatory environments and a lack of nursing...
(OMCL) Omnicell Analyst Upgrades Shares
We recently upgraded Omnicell, Inc. (OMCL) to an ‘Outperform’ with a target price of $15.50 based on a P/S of 2.2x our fiscal 2010 revenue estimate of $225 million. The company’s strong long-term outlook...
(OMCL) Omnicell Analysts Maintain Neutral Rating
We recently reiterated our Neutral rating on Omnicell, Inc. (OMCL) with a target price of $15.50.
Omnicell reported disappointing results in the fourth quarter and fiscal 2009. In the fourth quarter,...
(OMCL) Omnicell Enters New Contract With Carolinas HealthCare System
Omnicell, Inc. (OMCL) recently entered into a new contract with Carolinas HealthCare System (CHS) whereby the latter has selected Omnicell’s OmniRx automated medication dispensing cabinets (ADCs) to streamline...
(OMCL) Omnicell Launches New Product
Omnicell, Inc. (OMCL) recently launched a new product, Omnicell 14.0 with Anywhere RN, a software solution used in conjunction with Omnicell’s automated medication dispensing cabinets to ensure safe,...
(OMCL) Omnicell Eclipses Consensus Estimate
Omnicell Inc. (OMCL) reported third quarter 2009 earnings per share of 10 cents yesterday, beating the Zacks Consensus Estimate of 2 cents. However, earnings per share came below the year-ago figure of 18...